Stem cell research is very dynamic with research trends, focus, and approaches evolving rapidly - but increased government restrictions on the private sector have led to a steep decline in venture capital, which threatens to slow the pace of research and development.
New analysis from Frost&Sullivan, 'Strategic Analysis of the European Stem Cell Research Tools Market', finds that the market earned revenues of $148.4 million in 2011 and estimates this could reach $322 million in 2017. The segments covered include: bio-imaging and microscopy, cell biology tools, immunochemical, molecular biology tools, and protein biochemistry tools.